Literature DB >> 12681290

LIM-only protein FHL3 interacts with CDC25B2 phosphatase.

Valérie Mils1, Simon Ming Yuen Lee, Willy Joly, Eric Wong Chi Hang, Véronique Baldin, Mary Miu Yee Waye, Bernard Ducommun, Stephen Kwok Wing Tsui.   

Abstract

LIM domain proteins are important regulators of the growth, determination, and differentiation of cells. In this report, FHL3 (human four-and-a-half LIM-only protein 3) is shown to interact with human phosphatase CDC25B, a cell cycle regulator involved in the control of G2/M. We found that this interaction was specific to the CDC25B2 isoform. Deletion and point mutation studies indicated that the second LIM domain of FHL3 was essential for this interaction. FRET experiments in C2C12 cells showed that, although both proteins were colocated in the cytoplasm and the nucleus, they interacted only in the nucleus. Finally, we showed that FHL3 binding impaired neither CDC25B2 phosphatase activity nor its localization. Further work is now needed to elucidate the consequences of this interaction on myoblast fate decision and cycle control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681290     DOI: 10.1016/s0014-4827(03)00018-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.

Authors:  Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

2.  Identification and characterization of MT-1X as a novel FHL3-binding partner.

Authors:  Xin Cai; Jinfeng Wang; Xin Huang; Wenliang Fu; Wenrong Xia; Minji Zou; Yuanyuan Wang; Jiaxi Wang; Donggang Xu
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.